Effect of alginate encapsulation on the cellular transcriptome of human islets

Biomaterials

Volumn 32, Issue 33, 2011, Pages 8416-8425

  Vaithilingam, Vijayaganapathy ^a,b   Quayum, Nayeem ^c   Joglekar, Mugdha V ^d,f   Jensen, Jan ^c   Hardikar, Anandwardhan A ^d,g   Oberholzer, Jose ^e   Guillemin, Gilles J ^a   Tuch, Bernard E ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Australian Foundation for Diabetes Research   (Australia)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NATIONAL CENTRE FOR CELL SCIENCE   (India)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cell encapsulation; Diabetes; Gene expression; Hydrogel; Microencapsulation; Transplantation

Indexed keywords

ALGINATE ENCAPSULATION; CELL ENCAPSULATIONS; CLINICAL OUTCOME; CUT-OFF; EFFECT OF ENCAPSULATION; GENOMICS ANALYSIS; HUMAN ISLETS; IMMUNE REJECTION; IN-VIVO; MICROARRAY ANALYSIS; MICROENCAPSULATION; MINIMAL EFFECTS; NOD-SCID MICE; PERITONEAL CAVITY; PROTEIN EXPRESSIONS; TRANSCRIPTOMES; VASCULARISATION;

BARIUM; BIOCHEMISTRY; GENE EXPRESSION; HYDROGELS; MEDICAL PROBLEMS; PACKAGING; RNA; TISSUE; TISSUE CULTURE; TRANSPLANTATION (SURGICAL);

ENCAPSULATION;

ALGINIC ACID; MESSENGER RNA; TRANSCRIPTOME;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL VIABILITY; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INSULIN RELEASE; MALE; MICROARRAY ANALYSIS; MICROENCAPSULATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VASCULARIZATION; WESTERN BLOTTING;

ALGINATES; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD; MICE, SCID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME; UP-REGULATION;

MUS;

EID: 80052968751     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.06.044     Document Type: Article

References (36)

1. Shapiro A.M.J., Lakey J.R.T., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
2. Vaithilingam V., Sundaram G., Tuch B.E. Islet cell transplantation. Curr Opin Organ Trans 2008, 13:1-6.
3. de Vos P., Faas M.M., Strand B., Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006, 32:5603-5617.
4. Silva A.I., de Matos A.N., Brons I.G., Mateus M. An overview on the development of a bio-artificial pancreas as a treatment of insulin-dependent diabetes mellitus. Med Res Rev 2006, 26:181-182.
5. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Calabrese G., et al. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 2006, 29:137-138.
6. Tuch B.E., Keogh G.W., Williams L.J., Wu W., Foster J.L., Vaithilingam V., et al. Safety and viability of microencapsulated human islets transplanted into diabetic humans. Diabetes Care 2009, 32:1887-1889.
7. de Groot M., Schuurs T.A., van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J Surg Res 2004, 121:141-150.
8. de Haan B.J., Faas M.M., de Vos P. Factors influencing insulin secretion from encapsulated islets. Cell Transplant 2003, 12:617-625.
9. de Vos P., Van Straaten J.F., Nieuwenhuizen A.G., de Groot M., Ploeg R.J., De Haan B.J., et al. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?. Diabetes 1999, 48:1381-1388.
10. Van Schilfgaarde R., de Vos P. Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J Mol Med 1999, 77:199-205.
11. Simpson N.E., Grant S.C., Gustavsson L., Peltonen V.M., Blackband S.J., Constantinidis I. Biochemical consequences of alginate encapsulation: a NMR study of insulin-secreting cells. Biomaterials 2006, 27:2577-2586.
12. Ricordi C., Lacy P.E., Scharp D.W. Automated islet isolation from human pancreas. Diabetes 1989, 38:1140-1142.
13. Qi M., Strand B.L., Mørch Y., Lacík I., Wang Y., Salehi P., et al. Encapsulation of human islets in novel inhomogeneous alginate-Ca2+/Ba2+ microbeads: in vitro and in vivo function. Artif Cells Blood Substit Immobil 2008, 36:403-420.
14. Foster J.L., Williams G., Williams L.J., Tuch B.E. Differentiation of transplanted microencapsulated fetal pancreatic cells. Transplantation 2007, 83:1440-1448.
15. Joglekar M.V., Patil D., Joglekar V.M., Rao G.V., Reddy D.N., Mitnala S., et al. The miR-30 family microRNAs confer epithelial phenotype to human pancreatic islets. Islets 2009, 1:137-147.
16. Gao S.Y., Lees J.G., Wong J.C., Croll T.I., George P., Cooper-White J.J., et al. Modeling the adhesion of human embryonic stem cells to poly(lactic-co-glycolic acid) surfaces in a 3D environment. J Biomed Mater Res A 2010, 92:683-692.
17. Pfaffl M. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:2002-2007.
18. Lee I., Wang L., Wells A.D., Ye Q., Han R., Dorf M.E., et al. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. J Immunol 2003, 171:6929-6935.
19. Abdi R., Means T.K., Luster A.D. Chemokines in islet allograft rejection. Diabetes Metab Res Rev 2003, 19:186-190.
20. Piemonti L., Leone B.E., Nano R., Saccani A., Monti P., Maffi P., et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 2002, 51:55-65.
21. Schroppel B., Zhang N., Chen P., Chen D., Bromberg J.S., Murphy B. Role of donor-derived monocyte chemoattractant protein-1 in murine islet transplantation. J Am Soc Nephrol 2005, 16:444-451.
22. Bravo-Egana V., Rosero S., Molano R.D., Pileggi A., Ricordi C., Dominguez-Bendala J., et al. Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem. Biophys. Res. Commun 2008, 366:922-926.
23. Tang X., Tang G., Ozcan S. Role of microRNAs in diabetes. Biochim Biophys Acta 2008, 779:697-701.
24. Joglekar M.V., Joglekar V.M., Hardikar A.A. Expression of islet-specific microRNAs during human pancreatic development. Gene Expr Patterns 2009, 9:109-113.
25. Stabler C., Wilks K., Sambanis A., Constantinidis I. The effects of alginate composition on encapsulated bTC3 cells. Biomaterials 2001, 22:1301-1310.
26. Simpson N.E., Stabler C.L., Sambanis A., Constantinidis I. The role of the CaCl2-guluronic acid interaction on alginate encapsulated bTC3 cells. Biomaterials 2004, 25:2603-2610.
27. King A., Andersson A., Strand B.L., Lau J., Skjak-Braek G., Sandler S. The role of capsule composition and biologic responses in the function of transplanted microencapsulated islets of Langerhans. Transplantation 2003, 76:275-279.
28. Klock G., Frank H., Houben R., Zekorn T., Horcher A., Siebers U., et al. Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 1994, 40:638-643.
29. de Vos P., De Haan B., Pater J., Van Schilfgaarde R. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. Transplantation 1996, 62:893-899.
30. Bunger C.M., Gerlach C., Freier T., Schmitz K.P., Pilz M., Werner C., et al. Biocompatibility and surface structure of chemically modified immunoisolating alginate-PLL capsules. J Biomed Mater Res 2003, 67:1219-1227.
31. Johansson H., Lukinius A., Moberg L., Lundgren T., Berne C., Foss A., et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005, 54:1755-1762.
32. Gaber A.O., Fraga D. Advances in long-term islet culture: the memphis experience. Cell Biochem Biophys 2004, 40:49-54.
33. Schmied B.M., Ulrich A., Matsuzaki H., Ding X., Ricordi C., Weide L., et al. Transdifferentiation of human islet cells in a long-term culture. Pancreas 2001, 23:157-171.
34. Korbutt G.S., Mallett A.G., Ao Z., Flashner M., Rajotte R.V. Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation. Diabetologia 2004, 47:1810-1818.
35. Zhao M., Christie M.R., Heaton N., George S., Amiel S., Cai H.G. Amelioration of streptozotocin-induced diabetes in mice using human islet cells derived from longterm culture in vitro. Transplantation 2002, 73:1454-1460.
36. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.